Pituitary apoplexy after somatostatin analogue administration: coincidental or causative? (Record no. 23163798)

MARC details
000 -LEADER
fixed length control field 01237 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516173906.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201503s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1365-2265
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/cen.12339
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bakiri, Fawzi
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150330
245 00 - TITLE STATEMENT
Title Pituitary apoplexy after somatostatin analogue administration: coincidental or causative?
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical endocrinology
Date of publication, distribution, etc. Sep 2014
300 ## - PHYSICAL DESCRIPTION
Extent 471-3 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pituitary Apoplexy
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pituitary Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Somatostatin
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Herrera, Javier
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Riestra, Maria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Perrichot, Olivier
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pertierra, Joaquin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bruno, Oscar Domingo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brue, Thierry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Castinetti, Frederic
773 0# - HOST ITEM ENTRY
Title Clinical endocrinology
Related parts vol. 81
-- no. 3
-- p. 471-3
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/cen.12339">https://doi.org/10.1111/cen.12339</a>
Public note Available from publisher's website

No items available.